Probiotics in gastroenterology: indications and future perspectives
The DOI matches its Crossref record.
Abstract
Nowadays. there is a growing interest in probiotics as a safe way of changing the intestinal bacterial flora. Probiotics may have potential in several gastroenterological conditions, especially when the intestinal flora has been disturbed. Most scientific evidence is available for diarrhoea patients treated with Lactobacillus GG, Lactobacillus reuteri or Saccharomyces boulardii. Meta-analyses have shown an overall reduction in the risk of antibiotic-associated diarrhoea during treatment with probiotics, and benefits have also been demonstrated for patients with rota-virus-associated diarrhoea. Patients with inflammatory bowel disease, an inflammatory disorder characterized by a change in the intestinal flora, are another important target group for which probiotics may be beneficial. It has been claimed that in ulcerative colitis and Crohn disease patients, lactobacilli, S. boulardii and Escherichia coli reduce relapses. but most studies were not placebo-controlled. A reduction in relapses has also been demonstrated in pouchitis patients treated with a multispecies probiotic. Irritable bowel syndrome might be another clinical indication for probiotic therapy, but results of clinical trials performed in these patients are inconsistent. Additionally, probiotics may improve lactose absorption. Helicobacter pylori eradication and constipation. Finally, in animal models of colorectal cancer, treatment with probiotics reduces the prevalence of this disease, and in humans the amount of genotoxic substances in faeces has been reduced. In conclusion, the results of studies on the effects of probiotics in gastrointestinal conditions are encouraging. but well-designed placebo-controlled studies are warranted before recommendations for therapeutic or preventive use can be given. Many issues still have to be resolved, including optimal dose and duration of treatment, selection of and differences between the several available probiotic strains, and, importantly, their mechanisms of actions have to be elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The role of the intestinal microbiota in the development of atopic disorders
Penders, J., Stobberingh, E. E., Brandt, P. A. V. D., & Thijs, C. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01462.x · Cited by 437
Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood
Penders, J., Gerhold, K., Stobberingh, E. E., Thijs, C., Zimmermann, K., Lau, S., & Hamelmann, E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.043 · Cited by 298
A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria
Botić, T., Klingberg, T. D., Weingartl, H., & Cencič, A. (2007) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2006.10.044 · Cited by 163
Diop, L., Guillou, S., & Durand, H. (2008) · Nutrition Research · doi:10.1016/j.nutres.2007.10.001 · Cited by 162
Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation
BU, L., CHANG, M., NI, Y., CHEN, H., & CHENG, C. (2007) · Pediatrics International · doi:10.1111/j.1442-200x.2007.02397.x · Cited by 145
Metadata
- Authors
- D., G., D., J., E., S., Bogaard, A. V. D., M., R., & R., S.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2003-12-01
- Volume
- 38
- Issue
- 0
- Pages
- 15-23
- ISSN
- 0036-5521 (ISSN-L)
- OpenAlex
- W2012618827
- Cited by
- 68
- References
- 0
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotics in gastroenterology: indications and future perspectives. https://app.cochat.ai/papers/10.1080/00855920310002645
- The paper
- D., G., D., J., E., S., Bogaard, A. V. D., M., R., & R., S. (2003). Probiotics in gastroenterology: indications and future perspectives. Scandinavian Journal of Gastroenterology. https://doi.org/10.1080/00855920310002645
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.